INSTIL BIO INC (TIL) Stock Income Statement
NASDAQ:TIL - Nasdaq - US45783C2008 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 50.71M | 57.00M | 87.00M | 203.29M | 155.56M | |||
| Research and Development | 9.95M | N/A | 39.60M | 141.06M | 107.25M | |||
| Selling, General, and Administrative Expenses | 41.19M | 44.00M | 48.00M | 62.24M | 48.31M | |||
| Operating Income | -50.71M | -57.00M | -87.00M | -203.29M | -155.56M | |||
| Interest Income/Expense | -2.01M | N/A | 3.66M | 1.77M | -1.20M | |||
| Other Income/Expense | 4.12M | 1.41M | -580.00K | -560.00K | N/A | |||
| Non Recurring Items | -29.30M | -17.00M | -72.00M | -23.17M | N/A | |||
| Income Before Taxes | -78.12M | -74.00M | -156.00M | -225.25M | -156.76M | |||
| Income Tax | N/A | N/A | 0.00 | -2.07M | 40.00K | |||
| Net Income | -78.12M | -74.00M | -156.00M | -223.18M | -156.79M | |||
| EBITDA | -47.59M | -53.39M | -82.24M | -197.30M | -152.81M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -11.97 | -11.36 | -24.00 | -1.72 | -1.48 | |||
| Non GAAP EPS | -11.97 | -11.39 | -23.99 | -6.11 | -1.69 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD